Abstract

Background: Cerebral glucose hypometabolism is consistently observed in individuals with Alzheimer’s disease (AD), as well as in young cognitively normal carriers of the Ε4 allele of Apolipoprotein E (APOE), the strongest genetic predictor of late-onset AD. While this clinical feature has been described for over two decades, the mechanism underlying these changes in cerebral glucose metabolism remains a critical knowledge gap in the field.

Methods: Here, we undertook a multi-omic approach by combining single-cell RNA sequencing (scRNAseq) and stable isotope resolved metabolomics (SIRM) to define a metabolic rewiring across astrocytes, brain tissue, mice, and human subjects expressing APOE4.

Document Type

Article

Publication Date

12-2021

Digital Object Identifier (DOI)

10.1186/s13024-021-00483-y

Plum Print visual indicator of research metrics
PlumX Metrics
  • Citations
    • Citation Indexes: 47
  • Usage
    • Downloads: 139
    • Abstract Views: 27
  • Captures
    • Readers: 85
  • Mentions
    • News Mentions: 1
  • Social Media
    • Shares, Likes & Comments: 52
see details

Share

COinS